In gratitude of the loyal support of our members, the CNS is offering complimentary 2021 Annual Meeting registration to all members! Learn more.

  • Long-term outcomes of endovascular aneurysm treatment with intraoperative thrombus formation

    Final Number:
    159

    Authors:
    Isaac Josh Abecassis; Ryan Morton MD; Cory Kelly BS; Basavaraj Ghodke MD; Danial K. Hallam MD, MSc; Louis J. Kim MD; Michael Robert Levitt MD

    Study Design:
    Other

    Subject Category:
    Aneurysm/Subarachnoid Hemorrhage

    Meeting: AANS/CNS Cerebrovascular Section 2018 Annual Meeting

    Introduction: Endovascular treatment of intracranial aneurysms can be complicated by thrombus formation, requiring administration of intra-arterial (IA) abciximab, a glycoprotein IIb/IIIa inhibitor. While the safety of this practice has been well established, few studies have examined the long-term angiographic outcomes.

    Methods: Single institution, retrospective review of all endovascular interventions for intracranial aneurysm treatment, over a 4-year period.

    Results: A total of 198 aneurysms were treated with endovascular techniques. Balloon assisted coiling (BAC) was used in 70 (35%) of cases, stent assisted coiling (SAC) in 32 (16%) of cases, primary coiling in 59 (29%), and flow diversion in 37 (19%). Thirty-two patients developed intraoperative thrombus treated with IA abiciximab (16%). Thrombus formed during BAC in 15/70 cases (21%) (p=0.159), SAC in 3/32 cases (9%) (p=0.307), and primary coiling in 14/59 (24%) (p=0.017). Gender, age, aneurysm location and rupture status were not statistically significant risk factors for development of intraoperative thrombus. Smoking status was related to thrombus formation; 17/32 (53%) patients in the thrombus group were active smokers compared to 49/166 (30%) in the control cohort (p=0.013). In the thrombus group, immediate Raymond-Roy Scale (RRS) 1 results were seen in 73% (n=23), while 27% (n=9) achieved RRS 2. Of these 9 patients with residual aneurysm, 8 had long term follow-up. Five of the 8 (63%) spontaneously resolved to RRS 1, while 3 (37%) aneurysm remnants persisted during follow-up. Of the 23 patients with immediate RRS 1, 15 (65%) had long term follow up, and only 1 (6.67%) developed aneurysm recurrence.

    Conclusions: Primary coiling and smoking status are predictors for intraoperative thrombus formation necessitating abiciximab therapy. Long-term aneurysm residual is rare despite abciximab treatment.

    Patient Care: Our research will identify risk factors for thrombus formation as well as aneurysm recanalization when intra-arterial abiciximab is used.

    Learning Objectives: By the conclusion of this session, participants should be able to: 1) recognize the frequency of intra-procedural thrombus formation during endovascular treatment of aneurysms, 2) identify risk factors for thrombus formation, and 3) understanding strategies for treating thrombus.

    References:

We use cookies to improve the performance of our site, to analyze the traffic to our site, and to personalize your experience of the site. You can control cookies through your browser settings. Please find more information on the cookies used on our site. Privacy Policy